Literature DB >> 26249703

Expression, purification, crystallization and X-ray crystallographic analysis of the periplasmic binding protein VatD from Vibrio vulnificus M2799.

Nao Miyano1, Tomoko Igarashi1, Hiroaki Kawano1, Katsushiro Miyamoto1, Takahiro Tsuchiya1, Koji Tomoo2, Hiroshi Tsujibo1.   

Abstract

Vibrio vulnificus is a halophilic marine microorganism which causes gastroenteritis and primary septicaemia in humans. An important factor that determines the survival of V. vulnificus in the human body is its ability to acquire iron. VatD is a periplasmic siderophore-binding protein from V. vulnificus M2799. The current study reports the expression, purification and crystallization of VatD. Crystals of both apo VatD and a VatD-desferrioxamine B-Fe(3+) (VatD-FOB) complex were obtained. The crystal of apo VatD belonged to space group P6422, while the crystal of the VatD-FOB complex belonged to space group P21. The difference in the two crystal forms could be caused by the binding of FOB to VatD.

Entities:  

Keywords:  Vibrio vulnificus; desferrioxamine B; iron; periplasmic binding protein; siderophore

Mesh:

Substances:

Year:  2015        PMID: 26249703      PMCID: PMC4528945          DOI: 10.1107/S2053230X15011759

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  12 in total

1.  The structure of the ferric siderophore binding protein FhuD complexed with gallichrome.

Authors:  T E Clarke; S Y Ku; D R Dougan; H J Vogel; L W Tari
Journal:  Nat Struct Biol       Date:  2000-04

2.  Cloning and characterization of vuuA, a gene encoding the Vibrio vulnificus ferric vulnibactin receptor.

Authors:  A C Webster; C M Litwin
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Role of catechol siderophore synthesis in Vibrio vulnificus virulence.

Authors:  C M Litwin; T W Rayback; J Skinner
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

5.  Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987.

Authors:  K C Klontz; S Lieb; M Schreiber; H T Janowski; L M Baldy; R A Gunn
Journal:  Ann Intern Med       Date:  1988-08-15       Impact factor: 25.391

6.  Clinical features and an epidemiological study of Vibrio vulnificus infections.

Authors:  C O Tacket; F Brenner; P A Blake
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

7.  Structure of vulnibactin, a new polyamine-containing siderophore from Vibrio vulnificus.

Authors:  N Okujo; M Saito; S Yamamoto; T Yoshida; S Miyoshi; S Shinoda
Journal:  Biometals       Date:  1994-04       Impact factor: 2.949

8.  Vibrio vulnificus. Man and the sea.

Authors:  J M Johnston; S F Becker; L M McFarland
Journal:  JAMA       Date:  1985-05-17       Impact factor: 56.272

9.  The RND protein is involved in the vulnibactin export system in Vibrio vulnificus M2799.

Authors:  Hiroaki Kawano; Katsushiro Miyamoto; Megumi Yasunobe; Masahiro Murata; Tomoka Myojin; Takahiro Tsuchiya; Tomotaka Tanabe; Tatsuya Funahashi; Takaji Sato; Takashi Azuma; Yoshiki Mino; Hiroshi Tsujibo
Journal:  Microb Pathog       Date:  2014-09-06       Impact factor: 3.738

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  1 in total

Review 1.  Iron-Utilization System in Vibrio vulnificus M2799.

Authors:  Katsushiro Miyamoto; Hiroaki Kawano; Naoko Okai; Takeshi Hiromoto; Nao Miyano; Koji Tomoo; Takahiro Tsuchiya; Jun Komano; Tomotaka Tanabe; Tatsuya Funahashi; Hiroshi Tsujibo
Journal:  Mar Drugs       Date:  2021-12-17       Impact factor: 5.118

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.